XML 41 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Schedule of Stock-Based Compensation Expense

Stock-based compensation expense for the nine months ended September 30, 2021 and 2020 was classified in the condensed consolidated statement of operations as follows:

 

 

 

Nine Months Ended September 30,

 

 

 

2021

 

 

2020

 

 

 

(000’s)

 

 

 

 

 

 

 

 

Research and development

 

$

476

 

 

$

486

 

General and administrative

 

 

2,367

 

 

 

2,480

 

Total

 

$

2,843

 

 

$

2,966

 

Schedule of Restricted Share Activity A summary of the Company’s restricted stock activity during the nine months ended September 30, 2021 is as follows:

 

 

 

Shares

 

 

Fair Value

 

Weighted Average Fair Value

 

(000’s)

 

 

Per Share

 

Unvested, December 31, 2020

 

 

896

 

 

$

1.78

 

Granted

 

 

 

 

$

 

Vested

 

 

(273

)

 

$

1.82

 

Forfeited or canceled

 

 

(63

)

 

$

1.62

 

Unvested, September 30, 2021

 

 

560

 

 

$

1.78

 

Stock Options  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Schedule of Weighted Average Assumptions on Grant Date Fair Value for Options Granted

The weighted average assumptions used in the Black-Scholes pricing model to determine the fair value of stock options granted during the nine months ended September 30, 2021 and 2020 were as follows:

 

 

Nine Months Ended

 

 

September 30,

 

 

2021

 

 

2020

 

Expected term (in years)

 

6.1

 

 

 

6.0

 

Risk-free rate

 

0.79

%

 

 

0.36

%

Expected volatility

 

90

%

 

 

140

%

 

2020 Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Stock Option Activity

The following table summarizes the stock option activity for the 2020 Plan:

 

 

 

 

 

 

 

Weighted

 

 

Weighted

 

 

 

Number of

 

 

Average

 

 

Average

 

 

 

Unvested

 

 

Exercise

 

 

Remaining

 

 

 

Options

 

 

Price

 

 

Contractual

 

 

 

(000’s)

 

 

Per Share

 

 

Life (in years)

 

Outstanding at December 31, 2020

 

 

2,159

 

 

$

5.00

 

 

 

9.1

 

Granted

 

 

1,647

 

 

$

5.15

 

 

 

9.5

 

Exercise

 

 

 

 

$

5.00

 

 

 

 

Forfeited/cancelled

 

 

(286

)

 

$

5.00

 

 

 

 

Outstanding at September 30, 2021

 

 

3,520

 

 

$

5.07

 

 

 

9.2

 

Vested at September 30, 2021

 

 

1,208

 

 

$

5.00

 

 

 

8.9